Sr. Clinical Research Associate/Clinical trial Manager
Aspa Therapeutics
This listing was originally posted on Aspa Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moMavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
Company Overview
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. Founded in 2015, the company has built a portfolio of 20+ drug development programs spanning preclinical to late-stage development across multiple therapeutic areas.
QED Therapeutics, an affiliate of BridgeBio Pharma, is dedicated to developing targeted treatments for FGFR-driven skeletal dysplasia, focusing on Achondroplasia (ACH) and Hypochondroplasia (HCH). Achondroplasia is the most common form of genetically driven short stature, and Hypochondroplasia is a genetic condition that affects the way bones grow; both conditions can lead to significant medical complications throughout life. With our investigational therapeutic candidate, infigratinib, we seek to deliver meaningful treatment options that address the underlying cause of these conditions and improve outcomes for children and families living with ACH and HCH.
What You’ll Do
As a Sr. Clinical Research Associate/Clinical Trial Manager, you will collaborate within the Clinical Operations team to support the timely conduct of clinical studies according to protocols, GCP, SOPs, and applicable regulations. You will be responsible for performing quality study oversight processes, including monitoring communications with site staff and clinical vendors, and reviewing monitoring trip reports.
Where You'll Work
Experience using M.S. Office Suite (Excel, Word, PowerPoint) and SmartSheet
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For BridgeBio Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Aspa Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Gene Therapy
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo